Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Cancer Surgery Trials

Pennsylvania

Cancer surgery and procedure trials in Pennsylvania

99 cancer surgery and procedure studies are recruiting participants at sites in 66 cities across Pennsylvania as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 350-9284
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Pennsylvania by city

Cities with the most studies recruiting right now.

Every Pennsylvania city with a recruiting study

By research area: Lymphoma (27), Lung Cancer (24), Breast Cancer (18), Prostate Cancer (12), Pancreatic Cancer (10), Melanoma (8).

Philadelphia (60), Pittsburgh (55), Danville (27), Allentown (23), Wilkes-Barre (22), Hershey (19), Monroeville (18), Erie (17), Bethlehem (16), Lewisburg (15), Dickson City (13), Greensburg (13), Hazleton (13), York (13), Chambersburg (12), Ephrata (12), Lebanon (12), Mechanicsburg (12), Willow Grove (12), East Stroudsburg (11), Gettysburg (11), Harrisburg (11), Wynnewood (11), Chadds Ford (10), Media (10), Paoli (10), West Reading (10), Bryn Mawr (9), Sayre (9), Scranton (9), Beaver (8), Indiana (8), Seneca (8), Washington (8), Farrell (7), New Castle (7), Carlisle (6), Cranberry Township (6), Johnstown (6), N. Huntingdon (6), Natrona Heights (6), Williamsport (6), Butler (5), Hanover (5), Jefferson Hills (5), Moon Township (5), Uniontown (5), West Mifflin (5), Wexford (5), Altoona (4), Easton (4), McKeesport (4), Phoenixville (4), Pottsville (4), Quakertown (4), Meadville (3), Mount Pleasant (3), Reading (3), Stroudsburg (3), East Norriton (2), Abington (1), Lancaster (1), Meadowbrook (1), North Huntingdon (1), Pottstown (1), Wellsboro (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Pennsylvania

Basic details from each study's public record (the 12 most recently updated of 99). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Pittsburgh
    Registry record
    NCT03606967 · updated
  2. Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

    • Phase 1
    • Ages 12 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Pittsburgh
    Registry record
    NCT05372640 · updated
  3. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    • Phase 2
    • All ages
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Allentown · Altoona · Bethlehem · and 14 more U.S. locations
    Registry record
    NCT05564377 · updated
  4. Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Danville · Dickson City · Hazleton · and 6 more U.S. locations
    Registry record
    NCT07391774 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Pennsylvania on ClinicalTrials.gov.

Lung cancer: recently updated in Pennsylvania

  1. Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Philadelphia · Pittsburgh
    Registry record
    NCT04665739 · updated
  2. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Allentown · Bethlehem · Bryn Mawr · and 13 more U.S. locations
    Registry record
    NCT06498635 · updated
  3. JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Texas Southwestern Medical Center
    Recruiting in
    Pittsburgh
    Registry record
    NCT02468024 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Pennsylvania on ClinicalTrials.gov.

Prostate cancer: recently updated in Pennsylvania

  1. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Allentown · Bethlehem · East Stroudsburg · and 6 more U.S. locations
    Registry record
    NCT03866382 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Pennsylvania on ClinicalTrials.gov.

Lymphoma: recently updated in Pennsylvania

  1. Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

    • Phase 2
    • Up to 365 days
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Allentown · Danville · Hershey · and 2 more U.S. locations
    Registry record
    NCT06317662 · updated
  2. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Philadelphia
    Registry record
    NCT06337318 · updated
  3. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Recruiting in
    Allentown · Danville · Hershey · and 2 more U.S. locations
    Registry record
    NCT04726241 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Pennsylvania on ClinicalTrials.gov.

Pancreatic cancer: recently updated in Pennsylvania

  1. APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Media · Paoli · Philadelphia · and 1 more U.S. location
    Registry record
    NCT04858334 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Pennsylvania on ClinicalTrials.gov.

Ask about studies in Pennsylvania

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.

Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 350-9284

or send a short form

How should we reach you?

Call